📰 Study Results News
Page 45 - Study Results News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Results. Real-time updates on events, politics, business and more.
February 8, 2024
/PRNewswire/ -- CBD Nationwides latest study reveals a 90% spike in Delta 8 THC searches in states banning recreational cannabis, highlighting the significant...
February 8, 2024
Break out that olive oil, y'all! As CNN reports, a fascinating new study conducted by Rush University researchers showed that introducing healthy lifestyle habits helped to lower symptoms of dementia and Alzheimer's in patients already exhibiting warning signs of disease. Dementia, Alzheimer's, and similar neurodegenerative diseases are devastating conditions that largely remain without a cure. And […]
December 27, 2023
/PRNewswire/ -- A double-blind, placebo-controlled clinical trial of Qualia Senolytic showed a statistically significant reduction in issues related to joint...
November 24, 2023
After more than four years of study, analysis, and stakeholder engagement, the owners of the Eklutna Hydroelectric Project have released a draft program to protect, mitigate damages to, and enhance fi. . .
November 14, 2023
Intermittent fasting is associated with higher energy and improved mood, a large study by researchers in Britain confirmed.
October 25, 2023
New research has shed light on the potential health risks associated with the use of smokeless tobacco, particularly in regions where it remains prevalent. A study in Bangladesh has revealed a...
October 8, 2023
Discover top-rated Indiana small cities - Carmel, Westfield, Fishers, and more. See WalletHub's rankings for 2023's Best Small Cities in America
October 7, 2023
Discover top-rated Indiana small cities - Carmel, Westfield, Fishers, and more. See WalletHub's rankings for 2023's Best Small Cities in America
October 6, 2023
Discover top-rated Indiana small cities - Carmel, Westfield, Fishers, and more. See WalletHub's rankings for 2023's Best Small Cities in America
September 29, 2023
GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight loss at 28 days supporting once-daily...